Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07413068

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Sponsor: Qilu Hospital of Shandong University

View on ClinicalTrials.gov

Summary

Recruit patients with cholelithiasis with concomitant choledocholithiasis into the cohort, and assign them to undergo endoscopic transpapillary gallbladder-preserving cholecystolithotomy or ERCP plus laparoscopic cholecystectomy or conservative treatment based on patient preference. Collect clinical data and patient-reported outcomes regularly at baseline and during follow-up in the cohort. Assess the clinical safety of ERCP-GPC and LC by evaluating the clinical success rate of treatment as well as the incidence of short-term and long-term postoperative complications; investigate the efficacy differences among endoscopic transpapillary gallbladder-preserving cholecystolithotomy or ERCP plus laparoscopic cholecystectomy or conservative treatment in managing cholelithiasis with concomitant choledocholithiasis.

Official title: Comparative Study of ERCP, ERCP Plus Laparoscopic Cholecystectomy, and Conservative Management in Patients With Concomitant Choledocholithiasis and Cholecystolithiasis.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

300

Start Date

2025-12-01

Completion Date

2030-12

Last Updated

2026-02-17

Healthy Volunteers

No

Interventions

PROCEDURE

endoscopic transpapillary gallbladder-preserving

Based on the patient's preference, they will receive the following treatment:endoscopic transpapillary gallbladder-preserving

PROCEDURE

ERCP plus Laparoscopic Cholecystectomy

Based on the patient's preference, they will receive the following treatment:ERCP plus Laparoscopic Cholecystectomy

DRUG

Conservative treatment

Based on the patient's preference, they will receive the following treatment:ursodeoxycholic acid for stone dissolution,ESWL or symptomatic and supportive care.

Locations (1)

Qilu Hospital of Shandong University

Jinan, Shandong, China